{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:21:09Z","timestamp":1780579269851,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jmoldx.2025.06.007","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:22:37Z","timestamp":1753226557000},"page":"989-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"27","author":[{"given":"Lauren M.","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Sainger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-4374","authenticated-orcid":false,"given":"Paulina","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2465-5469","authenticated-orcid":false,"given":"Jillian","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-9179","authenticated-orcid":false,"given":"Joshua D.","family":"Wemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Patay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2025.06.007_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70326","article-title":"Recent developments and evolving therapeutic strategies in KMT2A-rearranged acute leukemia","volume":"13","author":"Yin","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib2","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.3390\/ijms25169023","article-title":"KMT2A rearrangements in leukemias: molecular aspects and therapeutic perspectives","volume":"25","author":"Guarnera","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(09)70369-9","article-title":"Genetic aberrations in paediatric acute leukaemias and implications for management of patients","volume":"11","author":"Szczepa\u0144ski","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib4","doi-asserted-by":"crossref","first-page":"26340","DOI":"10.1073\/pnas.2014732117","article-title":"Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23\/KMT2A","volume":"117","author":"Bill","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib5","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.22.02120","article-title":"Measurable residual disease and fusion partner independently predict survival and relapse risk in childhood KMT2A-rearranged acute myeloid leukemia: a study by the international Berlin-Frankfurt-Munster study group","volume":"41","author":"van Weelderen","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41408-021-00557-6","article-title":"Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements","volume":"11","author":"Issa","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib8","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib9","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/cncr.34728","article-title":"Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation","volume":"129","author":"Nguyen","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cancergen.2019.12.005","article-title":"Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion","volume":"241","author":"Blackburn","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/biomedicines9080924","article-title":"BTK, NuTM2A, and PRPF19 are novel KMT2A partner genes in childhood acute leukemia","volume":"9","author":"Zerkalenkova","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib12","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/bjh.17183","article-title":"A novel KMT2A\u2013USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia","volume":"192","author":"Jin","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-024-01632-8","article-title":"Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead","volume":"17","author":"Nadiminti","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PPO.0000000000000571","article-title":"Menin inhibitors in acute myeloid leukemia-what does the future hold?","volume":"28","author":"Swaminathan","year":"2022","journal-title":"Cancer J"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib15","first-page":"54","article-title":"Therapeutic targeting of the menin-KMT2A interaction","volume":"8","author":"Freire","year":"2024","journal-title":"Ann Rev Cancer Biol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.gim.2022.01.001","article-title":"Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)","volume":"24","author":"Horak","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diag"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib19","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO scale for clinical actionability of molecular targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.3774","article-title":"CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer","volume":"49","author":"Griffith","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib21","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cancergen.2022.03.001","article-title":"Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions","volume":"264\u2013265","author":"Saliba","year":"2022","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccell.2016.05.011","article-title":"MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome","volume":"30","author":"Stavropoulou","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib26","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1101\/gad.1143403","article-title":"Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors","volume":"17","author":"Cozzio","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib27","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood-2016-10-691428","article-title":"Mouse models of MLL leukemia: recapitulating the human disease","volume":"129","author":"Milne","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib28","article-title":"MLL-rearranged leukemias - an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front Ped"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s11033-021-06958-x","article-title":"Sequence, structural and functional conservation among the human and fission yeast ELL and EAF transcription elongation factors","volume":"49","author":"Sweta","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib30","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1038\/s41467-022-32335-8","article-title":"Afadin couples RAS GTPases to the polarity rheostat Scribble","volume":"13","author":"Goudreault","year":"2022","journal-title":"Nat Com"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjad049","article-title":"Distinct roles of two SEC scaffold proteins, AFF1 and AFF4, in regulating RNA polymerase II transcription elongation","volume":"15","author":"Che","year":"2024","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/cr.2010.156","article-title":"TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine","volume":"20","author":"Zhang","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.791597","article-title":"ARMC subfamily: structures, functions, evolutions, interactions, and diseases","volume":"8","author":"Huang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib34","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/ijms23105319","article-title":"Wnt\/[beta]-catenin signalling and its cofactor BCL9L have an oncogenic effect in bladder cancer cells","volume":"23","author":"Kotolloshi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib35","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1093\/hmg\/dds386","article-title":"Kinetochore KMN network gene CASC5 mutated in primary microcephaly","volume":"21","author":"Genin","year":"2012","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/cancers15041219","article-title":"The role of CREBBP\/EP300 and its therapeutic implications in hematological malignancies","volume":"15","author":"Zhu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib37","doi-asserted-by":"crossref","first-page":"28010","DOI":"10.1074\/jbc.M110.116384","article-title":"Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity","volume":"285","author":"Levy-Adam","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41389-021-00309-y","article-title":"MYB oncoproteins: emerging players and potential therapeutic targets in human cancer","volume":"10","author":"Cicir\u00f2","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib39","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1038\/ncomms8367","article-title":"RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK\/NF-[kappa]B pathway","volume":"6","author":"Murakawa","year":"2015","journal-title":"Nat Comm"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1515\/BC.2011.072","article-title":"MLL-SEPTIN gene fusions in hematological malignancies","volume":"392","author":"Cerveira","year":"2011","journal-title":"Bio Chem"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41594-022-00857-w","article-title":"Structural basis of SNAPc-dependent snRNA transcription initiation by RNA polymerase II","volume":"29","author":"Rengachari","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044817","article-title":"The identification of a novel gene, MAPO2, that is involved in the induction of apoptosis triggered by O6-methylguanine","volume":"7","author":"Fujikane","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib43","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1182\/blood.V106.11.4345.4345","article-title":"Cryptic MLL, AF10, ARMC3 rearrangement in secondary AML creates ARMC3-MLL fusion that disrupts gene encoding armadillo repeats similar to major cancer genes","volume":"106","author":"Germano","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib44","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3324\/haematol.2012.076323","article-title":"Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias","volume":"98","author":"Lee","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fcell.2019.00081","article-title":"Rewiring the epigenetic networks in MLL-rearranged leukemias: epigenetic dysregulation and pharmacological interventions","volume":"7","author":"Chan","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/bjh.15436","article-title":"Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases","volume":"182","author":"Vega-Garc\u00eda","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib47","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12185-012-1180-0","article-title":"Disordered epigenetic regulation in MLL-related leukemia","volume":"96","author":"Zhang","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib48","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1128\/MCB.21.16.5678-5687.2001","article-title":"The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis","volume":"21","author":"Luo","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib49","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1101\/gr.268490.120","article-title":"A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes","volume":"31","author":"Harman","year":"2021","journal-title":"Genome Res"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib50","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2012-11-465120","article-title":"Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l","volume":"121","author":"Deshpande","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2013-09-525741","article-title":"MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia","volume":"124","author":"Manara","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2020.194563","article-title":"Keeping RNA polymerase II on the run: functions of MLL fusion partners in transcriptional regulation","volume":"1863","author":"Basu","year":"2020","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.jmoldx.2025.06.007_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2141.2010.08459.x","article-title":"Mechanisms of leukemogenesis by MLL fusion proteins","volume":"152","author":"Marschalek","year":"2011","journal-title":"Br J Haematol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:51:58Z","timestamp":1758703918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157825001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1525157825001734"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.06.007","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}